Bottom line
- Total investment $40K – $290K including a $30K franchise fee, 5.0% ongoing royalty.
- No Item 19 financial performance data disclosed — the franchisor chose not to publish revenue figures.
- Rated MODERATE with a risk score of 62/100. SBA loan default rate of 0.0% across 4 loans (below the industry average).
- No Item 19 financial performance representation. Without franchisor-disclosed revenue data, you'll need to gather unit economics directly from existing franchisees.
Item 1 · who you're contracting with
The Franchisor
Yale framework · single-unit ROIC
Returns Analysis
Pulls Item 7 (investment) and Item 19 (revenue) from this brand's FDD into the Yale unlevered-ROIC formula. Override any input to stress-test it against your own assumptions.
The model · Yale framework
What would one Signal Health Group unit return on the cash you put in?
Unlevered ROIC · per unit
45%
In Yale's "attractive" band (30–60%)
Overview
About
Signal Health Group appears to operate in healthcare services (likely telehealth, staffing, or home health). Franchisees likely manage client acquisition, service delivery/oversight, staff hiring/training, and compliance with healthcare regulations while paying 5% royalties to the franchisor.
Item 7 · what it costs
The Vitals
Item 19
Financial Performance
This franchisor did not disclose financial performance representations in Item 19, or our extractor could not parse them.
Item 20 · unit dynamics
The Growth Chart
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 12 · 13 states reported
The Territory Map
FDD Item 12 reports the state count, but the specific list isn't in our current data. The map will appear once we re-extract from the FDD or enough franchisee contacts are available.
13
states with franchisees (per FDD Item 12)
Government records
SBA Loan Data
Aggregated from SBA 7(a) loan disclosures, public data unique to FranchiseVerdict.
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
Early-stage health services franchise with no financial transparency, questionable franchisor stability, and unclear unit economics poses significant investment risk despite growth rate.
Score breakdown · what drove the 62 / 100 rating
- 01MEDNo Item 19 (Average Revenue/Net Income) disclosed — impossible to evaluate actual profitability or ROI
- 02HIGHGoing Concern status is FALSE, indicating potential financial instability at franchisor level
- 03MINORWide investment range ($40K-$290K) suggests unclear unit economics or highly variable startup costs
- 04MEDOnly 20 units system-wide is very small; 38.5% YoY growth may not offset limited support infrastructure
- 05HIGHNo litigation disclosed is positive, but combined with other factors suggests early-stage or underdeveloped franchise model
- 06MED5% royalty on undisclosed revenue means franchisees cannot project cash flow realistically
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
Item 11
Training & Operations
Item 20
Franchisee Contacts
Phone numbers extracted directly from this brand's FDD Item 20. After purchase, you'll also receive a list of validation questions tailored to this brand.
Franchisee contacts
15 numbers
One-time purchase · CSV download · Validation questions included
FDD download
Signal Health Group · FDD (2025) PDF